Ethiopia Joins Africa’s Leaders in Medicines Regulation with WHO Recognition
Written By Maxine Ansah
Get real time updates directly on you device, subscribe now.
|
Getting your Trinity Audio player ready...
|
Ethiopia has achieved a major milestone in its journey towards strengthening its health system, with the World Health Organization (WHO) formally recognising the country’s regulatory authority at Maturity Level 3 (ML3). This recognition places Ethiopia among just nine African nations with a regulatory framework that meets global standards for quality, safety, and efficacy of medicines and vaccines.
The recognition follows a rigorous benchmarking exercise led by WHO, which assessed the Ethiopian Food and Drug Authority (EFDA) against more than 250 indicators of regulatory performance. Maturity Level 3 is defined as a stable, well-functioning, and integrated regulatory system. Achieving this status means that Ethiopia now has the capacity to authorise medical products, oversee their quality, and monitor safety concerns effectively.
WHO Regional Director for Africa, Dr Mohamed Yakub Janabi, hailed the achievement as a “landmark moment” for both Ethiopia and the wider continent. He emphasised that strong regulatory systems are the foundation of universal health coverage, enabling patients to trust that their medicines are safe and effective.
The success is a result of sustained commitment from EFDA, supported by WHO’s Regional Office for Africa and its Country Office in Addis Ababa. The benchmarking process was completed in September 2025 and marks a significant step towards Ethiopia’s potential qualification as a WHO-listed Authority, a status that would allow the country to influence global regulatory standards further.
Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data, highlighted the direct impact of this milestone on public health. “Effective regulation saves lives,” she said, pointing out that reaching ML3 demonstrates Ethiopia’s leadership and determination to protect its population while contributing to regional and global health security.
Ethiopia now joins Egypt, Ghana, Nigeria, South Africa, Tanzania, Zimbabwe, Senegal, and Rwanda in reaching Maturity Level 3 on the continent. These countries are setting the pace for Africa’s role in strengthening medicines regulation and ensuring that safe, high-quality medical products are available to all communities.
The achievement is more than a technical victory. It is a powerful signal that African nations can drive regulatory excellence through persistence, collaboration, and investment in their health systems. For Ethiopia, it represents a step closer to universal health coverage and a healthier future for its people. For Africa, it is a reminder that regulatory leadership is not only possible but essential for safeguarding lives and shaping global standards in health care.